<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pharmacology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DCB0A98B-0396-4D46-B265-69C4DD448BA7"><gtr:id>DCB0A98B-0396-4D46-B265-69C4DD448BA7</gtr:id><gtr:firstName>Hendrik Willem</gtr:firstName><gtr:surname>van Veen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FF008333%2F1"><gtr:id>2697DFBE-0DA2-44D8-A8D7-73EAC2EAA788</gtr:id><gtr:title>Molecular mechanisms of multidrug binding by the bacterial ABC transporter Sav1866</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F008333/1</gtr:grantReference><gtr:abstractText>Multidrug transporters are very small molecular machines that are present at the surface of human cells and microorganisms. These ingenious machines provide the cell with a defense mechanism against toxic compounds which are harmful to them. The activity of multidrug transporters interferes with the drug-based control, also termed 'chemotherapy', of human tumours and infectious pathogenic microorganisms, in which drugs are designed to kill the cell. Multidrug transporters bind structurally unrelated drugs and toxins at the inside of the cell, and then move these compounds to the outside of the cell, away from the targets with which the drugs are supposed to interact. Hence, multidrug transporters act as drug pumps that are able to lower the drug concentration inside the cell to levels at which these drugs are inactive and useless. As drugs now have lost their therapeutic effects, the cell has become 'multidrug resistant'. This project focuses on the bacterial multidrug transporter Sav1866, which is very similar to one of the major multidrug pumps in human. Sav1866 is made by the pathogenic bacterium Staphylococcus aureus, but we use the non-pathogenic, food-grade bacterium Lactococcus lactis to study the properties of the pump. Sav1866 is particularly interesting as researchers have very recently been able to determine its three-dimensional structure. In this project, we study how Sav1866 recognizes and binds drugs. This knowledge might allow us to rationally design new drugs that can poison or circumvent the activity of these transport proteins in microorganisms and human cells to improve chemotherapy of cancers and infectious diseases.</gtr:abstractText><gtr:technicalSummary>Multidrug transporters mediate the extrusion of structurally unrelated drugs from prokaryotic and eukaryotic cells. As a result of this efflux activity, the cytoplasmic drug concentration in the cell is lowered to subtoxic levels, and, hence, cells become multidrug resistant. Multidrug transporters interfere with the chemotherapeutic treatment of cancers and infections by pathogenic microorganisms. This research proposal focuses on the membrane transporter Sav1866, a bacterial homologue of the human multidrug resistance P-glycoprotein, for which recently a high-resolution crystal structure was determined [Nature 443: 180-185 (2007)]. Sav1866 is an ATP-binding cassette (ABC) transporter containing one membrane domain with 6 transmembrane spanning segments and one nucleotide-binding domain. Similar to its homologue LmrA from Lactococcus lactis [EMBO J. 19: 2503-2514 (2000)] and MsbA from Escherichia coli [J. Biol. Chem. 278:35193-35198], Sav1866 is most likely active as a homodimer. In our recent functional studies on MsbA and Sav1866, we have identified regions in the membrane domains where change-in-specificity mutations, observed for P-glycoprotein [Trends Pharmacol. Sci. 27:195-203], might co-localise. In this project, we will study drug-protein interactions in Sav1866 is detail. In particular, we aim: (i) to identify locations of drug-binding surfaces in Sav1866 by cysteine crosslinking and by site-specific proteolytic cleavage, (ii) to use molecular docking techniques to predict drug-protein interactions, and (iii) to study structure-activity relationships in drug-binding surfaces and drug molecules. This strategy will add important new information about the molecular mechanisms by which this unique class of multidrug transporters recognizes its substrates, and may lead to the development of new drugs that could bypass or inhibit drug efflux in a clinical setting.</gtr:technicalSummary><gtr:fund><gtr:end>2011-05-11</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-05-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>301448</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our results support the notion that multidrug efflux pumps belonging to different classes and originating from different organisms can perform similar functions. Our work has contributed to the awareness that drug resistance in cancer and drug resistance in pathogenic microorganisms is connected by the presence of similar drug resistance mechanisms.</gtr:description><gtr:firstYearOfImpact>2008</gtr:firstYearOfImpact><gtr:id>4FB7F63E-B485-47C0-A0AD-87564904452B</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:sector>Chemicals,Education,Environment,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>In our studies on the localization of drug binding in the multidrug ABC exporter Sav1866 from Staphylococcus aureus, we set up new methods for cross-linking of the photo-activatable ethidium analogue ethidium mono azide. In addition, we used for the first time the antibiotic bleomycin as a chemical protease that, subsequent to its binding to Sav1866 (or any other target protein), can be activated to cleave the polypeptide backbone in close vicinity to its binding. Both methods will be extremely useful in studies on other multidrug binding proteins. In addition, methods were optimized to recover hydrophobic peptides derived from Sav1866, and to analyze these by mass spectrometry and N-terminal sequencing.</gtr:description><gtr:exploitationPathways>Multidrug resistance is a widespread phenomenon that can be based on drug efflux by multidrug efflux pumps. In animals and human, the efflux pumps play role in the resistance of tumors to chemotherapeutic agents during cancer treatment. Studies on the mechanisms of drug recognition and transport by these efflux pumps might allow the generation of inhibitors (modulators) that can re-sensitize drug-resistant tumors to anticancer drugs, and might allow the development of new drugs that are not extruded from the cell. As multidrug exporters have a significant influence on the pharmacokinetic properties of drugs in mammals, such new insights into drug recognition an transport will also allow optimization of the pharmacokinetic properties of drugs and their targeting to various parts in the body.</gtr:exploitationPathways><gtr:id>37F740F0-D81E-4762-8962-DAB4971919E0</gtr:id><gtr:sectors><gtr:sector>Education,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E05F16C7-DFD5-4CE9-830D-671C629F1BCF"><gtr:id>E05F16C7-DFD5-4CE9-830D-671C629F1BCF</gtr:id><gtr:title>Dissection of the conformational cycle of the multidrug/lipidA ABC exporter MsbA.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/704e2affebee518be565193c810581f8"><gtr:id>704e2affebee518be565193c810581f8</gtr:id><gtr:otherNames>Doshi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A68F0569-EBE7-424B-B50D-F8995D29DDE0"><gtr:id>A68F0569-EBE7-424B-B50D-F8995D29DDE0</gtr:id><gtr:title>A multidrug ABC transporter with a taste for salt.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/75cd0b6b7c2503fca63a29849004427a"><gtr:id>75cd0b6b7c2503fca63a29849004427a</gtr:id><gtr:otherNames>Velamakanni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D303930B-5214-4CED-B278-75B8DDBF7457"><gtr:id>D303930B-5214-4CED-B278-75B8DDBF7457</gtr:id><gtr:title>Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5eda7d2edbfb6854752b99c0490fee99"><gtr:id>5eda7d2edbfb6854752b99c0490fee99</gtr:id><gtr:otherNames>Welch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/830CA437-BDEF-4AEF-B7DB-1763AEC158F2"><gtr:id>830CA437-BDEF-4AEF-B7DB-1763AEC158F2</gtr:id><gtr:title>ABC Transporters in Microorganisms: Research, Innovation and Value as Targets Against Drug Resistance</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bb9b0bac4ee8ab7b09711840e1f23ea8"><gtr:id>bb9b0bac4ee8ab7b09711840e1f23ea8</gtr:id><gtr:otherNames>Gutmann, D. A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>978-1-904455-49-3</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D8E1ED6-E15C-4CBE-8469-73927890400D"><gtr:id>5D8E1ED6-E15C-4CBE-8469-73927890400D</gtr:id><gtr:title>Structural biology: Last of the multidrug transporters.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2ed97f3a6a6e1e5e153a501fc68a3cf4"><gtr:id>2ed97f3a6a6e1e5e153a501fc68a3cf4</gtr:id><gtr:otherNames>van Veen HW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/008BED69-1D44-4300-B268-2B198340AA10"><gtr:id>008BED69-1D44-4300-B268-2B198340AA10</gtr:id><gtr:title>Caught in the act: ATP hydrolysis of an ABC-multidrug transporter followed by real-time magic angle spinning NMR.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f7a1b3fd015cbe4a1a7b9ec733e6f9e"><gtr:id>6f7a1b3fd015cbe4a1a7b9ec733e6f9e</gtr:id><gtr:otherNames>Hellmich UA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97F9A75D-A067-4346-9D85-A51B02F49FB1"><gtr:id>97F9A75D-A067-4346-9D85-A51B02F49FB1</gtr:id><gtr:title>Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/38eae100762284d8141cbae8065f54fa"><gtr:id>38eae100762284d8141cbae8065f54fa</gtr:id><gtr:otherNames>Barrera NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94B35FCF-3A5F-452B-8FCC-1ADA9B3FE167"><gtr:id>94B35FCF-3A5F-452B-8FCC-1ADA9B3FE167</gtr:id><gtr:title>Molecular basis of multidrug transport by ABC transporters.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a5cf23a2ebde7362a1149368464231f8"><gtr:id>a5cf23a2ebde7362a1149368464231f8</gtr:id><gtr:otherNames>Seeger MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC16A888-7581-4DAB-823E-160CAA0045E1"><gtr:id>DC16A888-7581-4DAB-823E-160CAA0045E1</gtr:id><gtr:title>Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/75cd0b6b7c2503fca63a29849004427a"><gtr:id>75cd0b6b7c2503fca63a29849004427a</gtr:id><gtr:otherNames>Velamakanni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/079DBA08-CD73-44AF-8D38-8FD85D8CEA39"><gtr:id>079DBA08-CD73-44AF-8D38-8FD85D8CEA39</gtr:id><gtr:title>MacB ABC transporter is a dimer whose ATPase activity and macrolide-binding capacity are regulated by the membrane fusion protein MacA.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e33b44bdd6c90d8a5fe7d0d448d0e62"><gtr:id>5e33b44bdd6c90d8a5fe7d0d448d0e62</gtr:id><gtr:otherNames>Lin HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3130DA2F-D0B7-4655-A99F-8029E8C84E6E"><gtr:id>3130DA2F-D0B7-4655-A99F-8029E8C84E6E</gtr:id><gtr:title>Functional role of transmembrane helix 6 in drug binding and transport by the ABC transporter MsbA.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e52752a248dc5ba6ac1c395ae75b3e9a"><gtr:id>e52752a248dc5ba6ac1c395ae75b3e9a</gtr:id><gtr:otherNames>Woebking B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AE79B38A-561D-42F7-B4A3-E2B8173528B5"><gtr:id>AE79B38A-561D-42F7-B4A3-E2B8173528B5</gtr:id><gtr:title>Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4beefff2a422472744246f1e9efeab9c"><gtr:id>4beefff2a422472744246f1e9efeab9c</gtr:id><gtr:otherNames>Gutmann DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F008333/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>